Top companies

ASIANPAINT - 2875 (0.42%) AXISBANK - 1162.45 (0.24%) BAJAJFINSV - 1614 (1.15%) BAJFINANCE - 6903.05 (1.16%) BHARTIARTL - 1324.5 (-0.63%) BPCL - 610.15 (-1.41%) COALINDIA - 453.9 (0.03%) HDFCBANK - 1515.45 (-0.86%) HEROMOTOCO - 4551 (2.24%) HINDUNILVR - 2233.8 (0.31%) ICICIBANK - 1150.25 (-0.85%) INDUSINDBK - 1509 (1.33%) ITC - 435.35 (-0.61%) KOTAKBANK - 1623.65 (-1.02%) MARUTI - 12800 (0.79%) ONGC - 282.6 (-0.28%) RELIANCE - 2932 (0.15%) SBIN - 821 (-0.67%) TATAMOTORS - 1008 (0.74%) TATASTEEL - 164.75 (-1.58%) TCS - 3823.95 (-1.06%) TITAN - 3595 (0.28%) WIPRO - 462.4 (-0.12%)
TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

The page of SPARC. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 06-05-2024 is predicted based on technical analysis and should only be used as reference for learning purpose only.

Sector: Pharmaceuticals

Sun Pharma Advanced Research Company Limited


225.5   -11.85 (-4.99%)

As on 05 May, 2024 09:40 IST
Open 238.55
LTP 225.5
Previous Close 237.35
Day High 239.5
Day Low 225.5
Volume 2435455

SPARC Prediction / Intraday Stock Price Target

Disclaimer :- Intraday Stock & Index Prediction Levels are been generated everyday at 17:00 Hours for the next trading day. Stock or Index Prediction is done based on technical & strategic levels of the stock or index & can only be used as reference for study of charts & volume patterns. GrowMudra strictly recommends everyone to consult a certified financial advisor before initiating any trade in the stock market. GrowMudra strictly forbids anyone to take the above views as advisory & holds no responsibility on any financial losses or gain.

Peers


Company Name Price Change % Chg Day High Day Low Previous Close Volume
Sun Pharma Advanced Research Company Limited 225.5 -11.85 -4.99 239.5 225.5 237.35 2435455
Syncom Healthcare Limited 0 0 0 0 0 0 0

About Company


Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, dermatology, and Immunology. The company offers Elepsia XR, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension; and Phenobarbital injection for the treatment of neonatal seizures. In addition, it is developing SDN-037, a formulation of difluprednate for the treatment of inflammation and pain associated with ocular surgery that is in phase 3 clinical trial; PDP-716 to treat glaucoma, which is in phase 3 clinical trial; Vodobatinib (SCO-088) for the treatment of resistant chronic myelogenous leukemia that has completed a part A of the Phase 1 study; Vodobatinib (SCC-138), which is in phase 2 clinical trial to treat Parkinson's disease; SCD-044 for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial; and SCO-120 for the treatment of hormone receptor-positive, human epidermal receptor 2 negative, and metastatic breast cancer, which is in phase 1 clinical trial. The company was incorporated in 2006 and is based in Mumbai, India.

Top Gainers


Company LTP Change Gain
Hero-MotoCorp-Limited 4551 99.9 2.24 %
IndusInd-Bank 1509 19.75 1.33 %

Top Losers


Company LTP Change Loss
Tata-Steel-Limited 164.75 -2.65 -1.58 %
Bharat-Petroleum-Corporation-Limited 610.15 -8.75 -1.41 %

Growmudra © 2024 all right reserved

Crafted With ZEE WEB VALLEY

Partner With Us